As part of the NHS response to Coronavirus (COVID-19), we have made changes to the services we provide
COVID-19 Vaccine Clinical Trial
A study to evaluate efficacy and safety of a novel COVID-19 vaccine.
A Phase III clinical trial to assess efficacy and safety of a novel COVID-19 vaccine.
We are looking for volunteers to take part in our COVID-19 vaccine clinical trial. If you are aged 18-84 and in good health, you could be eligible to participate. The study involves 6 visits over a period of around 13 months. Reasonable travel expenses will be reimbursed.
Who can take part?
Midlands Partnership NHS Foundation Trust is looking for volunteers to participate in a clinical trial studying an investigational vaccine against COVID-19. The vaccine has recently completed preliminary testing in humans, showing promising initial results on antibody levels in healthy volunteers and no serious safety concerns identified to date. The vaccine now requires testing on a large scale and a study involving 9000 people in around 18 regions across the UK is starting. The aims to recruit around 500 volunteers aged 18-84 from the West Midlands area. The study aims to recruit a representative sample from the entire population so most people will be suitable. However, this clinical trial would not be suitable for those taking anticoagulant therapy (aspirin is fine) or anyone pregnant or aiming to become pregnant in the next year. Participants at higher risk from COVID-19 for any reason, e.g. due to their age, social situation or ethnicity, are particularly welcome.